Drug Profile
Herpes simplex vaccine - JN-International Medical Corporation
Alternative Names: ANTI-ID-1; ANTI-ID-2; ANTI-ID-3; JN-ANTI-IDLatest Information Update: 28 Aug 2019
Price :
$50
*
At a glance
- Originator JN-International Medical Corporation
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Herpes simplex virus infections
Most Recent Events
- 28 Aug 2019 No recent reports of development identified for phase-I development in Herpes-simplex-virus-infections in Cambodia (Parenteral)
- 07 Jul 2016 Phase-I clinical trials in Herpes simplex virus infections in Cambodia (Parenteral)